WILMINGTON, MA — Implant Sciences Corporation, a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced yesterday that it has completed shipment over 750 QS-B220 Desktop Explosives Trace Detectors across eleven European countries. These systems were sold between April and September, 2015, as EU airports sought to comply with new enhanced explosives screening requirements. Airport authorities that have selected Implant Sciences’ trace detection systems include those located in France, the Netherlands, Norway, Finland, Germany, Belgium, Austria, Poland, the Czech Republic, Cyprus, and Romania.
“Although the majority of these units were shipped and installed for the September 1 EU regulatory deadline for international airports, some orders, such as the 304 unit order to France, required an immediate shipment to the larger airports, with additional units to be shipped in 2016-2017,” stated Dr. Darryl Jones, Implant Sciences’ Executive Vice President, Global Sales and Marketing. “We are also continuing to receive and ship follow-on orders to our customers as these EU airports expand the implementation of ETD screening.”
“Over the past year, in anticipation of increased demand, we took significant steps to augment our production capacity. As a result, even with our unprecedented success in the European market over the last six months, our production team was able to systematically and effectively increase output to fulfill the orders,” stated Dr. Bill McGann, Implant Sciences’ CEO. “With quality at the forefront, we have built a sustainable and scalable production capacity to meet our expected demand for fiscal 2016 and for the years to come.”
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company’s team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 70 countries worldwide. The Company’s ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, CAAC and the Ministry of Public Safety in China, Russia FSB, STAC in France, and the German Ministry of the Interior. It has also received the 2015 GSN Airport/Seaport/Border Security Award for “Best Security Checkpoint”. All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company’s website at www.implantsciences.com.
(NOTE: The above press release is from Implant Sciences.)
Like Wilmington Apple on Facebook! Follow Wilmington Apple on Twitter! Subscribe to Wilmington Apple’s daily email newsletter HERE! Got a comment, question, photo, press release, or news tip? Email wilmingtonapple@gmail.com!
Wilmington Apple 